A
3.37
-4.26%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$99.3m
FY2019FY2025
Net income
−$89.5m
FY2019FY2025
Free cash flow
−$35.3m
FY2019FY2025
Shareholders' equity
$27.3m
FY2019FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $99.3m | $78.1m | $41.4m | $48.5m | $35.5m | $30.5m | $31.2m |
| Gross profit | −$25.3m | −$24.0m | $10.3m | $9.4m | $9.0m | $8.2m | $9.7m |
| Research and development | — | — | $761,561 | $725,577 | $619,259 | — | — |
| Operating income | −$72.4m | −$61.5m | −$12.5m | −$15.1m | −$13.4m | −$576,316 | −$5.3m |
| Net income | −$89.5m | −$63.6m | −$15.8m | −$61.0m | −$17.8m | $941,637 | −$6.7m |
| Diluted earnings per share | -13.16 | -9.50 | -5.32 | -2.35 | -0.68 | 0.18 | -0.99 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Total assets | $113.9m | $124.1m | $19.5m | $29.6m | $13.0m | $100.8m | $10.7m |
| Cash and short-term investments | $22.4m | $14.2m | $6.2m | $3.1m | $1.1m | $709,879 | $1.3m |
| Total liabilities | $87.8m | $65.4m | $33.6m | $36.1m | $41.0m | $10.4m | $23.4m |
| Debt | $126,179 | $12.3m | $170,897 | $360,800 | $18.8m | $13.1m | $6.3m |
| Shareholders' equity | $27.3m | $59.9m | −$12.9m | −$5.1m | −$26.8m | $90.3m | −$11.9m |
| Shares outstanding | 7m | 7m | 3m | 26m | 26m | 5m | 7m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Cash from operations | −$35.2m | −$47.4m | −$3.9m | $17,063 | −$14.1m | −$421,316 | −$1.0m |
| Capital spending | −$101,676 | −$45,753 | −$98,529 | −$3 | −$164,012 | −$4 | −$42,181 |
| Free cash flow | −$35.3m | −$47.4m | −$4.0m | $17,060 | −$14.3m | −$421,320 | −$1.1m |
Latest quarters
By quarter end
| Jun 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48.4m | $78.1m | $29.8m | $11.2m | $41.4m | $11.2m | $9.5m | $9.5m |
| Gross profit | −$15.1m | −$24.0m | −$8.5m | $3.6m | $10.3m | $3.6m | $1.5m | $1.5m |
| Operating income | −$37.5m | −$63.3m | −$27.2m | −$2.4m | −$14.9m | −$2.4m | −$4.8m | −$4.8m |
| Net income | −$37.1m | −$63.6m | −$27.7m | −$1.9m | −$15.8m | −$1.9m | −$6.0m | −$6.0m |
| Diluted earnings per share | -5.54 | -11.03 | -5.73 | -0.29 | -5.98 | -0.65 | -2.01 | -2.01 |
| Cash from operations | — | — | — | −$1.0m | — | −$1.0m | — | — |
| Total assets | $129.1m | $124.1m | $143.1m | $19.5m | $19.5m | $19.5m | $20.5m | $20.5m |
| Cash and short-term investments | — | — | $27.1m | $6.2m | — | $6.2m | $1.3m | $1.3m |
| Debt | $32.9m | $12.0m | $49,432 | $112,460 | — | $112,460 | $62,239 | $62,239 |
| Shareholders' equity | $22.8m | $59.9m | $95.8m | −$12.9m | −$12.9m | −$12.9m | −$17.2m | −$17.2m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 25.3% | 26.7% | — |
| Operating income | 68.5% | 162.9% | — |
| Net income | 13.6% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | -27.8% | -11.1% | -3.7% | — |
| Operating margin | -75.5% | -60.4% | -52.7% | — |
| Net margin | -86.3% | -86.0% | -74.0% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | -0.3 | -0.9 | -1.1 | -2.4 | -29.8 | 110.3 |
| Price to sales | 0.3 | 0.7 | 0.4 | 3.1 | 16.2 | 3.6 |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Return | -69% | 34% | -11% | -68% | 2% | 3% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 10-to-1 reverse split · 4 Aug 2025
- 10-to-1 reverse split · 1 Aug 2025
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.